Thera-SAbDab: the Therapeutic Structural Antibody Database

Matthew I. J. Raybould(University of Oxford), Claire Marks(University of Oxford), Alan P. Lewis(GlaxoSmithKline (United Kingdom)), Jiye Shi(UCB Pharma (United Kingdom)), Alexander Bujotzek(La Roche College), Bruck Taddese(AstraZeneca (United Kingdom)), Charlotte M. Deane(University of Oxford)
Nucleic Acids Research
September 25, 2019
Cited by 214Open Access
Full Text

Abstract

The Therapeutic Structural Antibody Database (Thera-SAbDab; http://opig.stats.ox.ac.uk/webapps/therasabdab) tracks all antibody- and nanobody-related therapeutics recognized by the World Health Organisation (WHO), and identifies any corresponding structures in the Structural Antibody Database (SAbDab) with near-exact or exact variable domain sequence matches. Thera-SAbDab is synchronized with SAbDab to update weekly, reflecting new Protein Data Bank entries and the availability of new sequence data published by the WHO. Each therapeutic summary page lists structural coverage (with links to the appropriate SAbDab entries), alignments showing where any near-matches deviate in sequence, and accompanying metadata, such as intended target and investigated conditions. Thera-SAbDab can be queried by therapeutic name, by a combination of metadata, or by variable domain sequence - returning all therapeutics that are within a specified sequence identity over a specified region of the query. The sequences of all therapeutics listed in Thera-SAbDab (461 unique molecules, as of 5 August 2019) are downloadable as a single file with accompanying metadata.


Related Papers

No related papers found

Powered by citation graph analysis